Clinical Trial Update: Once Daily Immunosuppression Regimen [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a once-daily immunosuppression regimen in kidney transplant recipients was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Unspecified once-daily immunosuppression regimen

Snippet

Sponsor: Washington University School of Medicine | Conditions: Kidney Transplant; Complications | Phase 4 | Status: TERMINATED | Results posted: 2025-01-22